Location: Home
  • search
  • go
  • Relate News
  • 8/25/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q12
  • 8/25/2023NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023Drug R&D and Product Registration News Digest August 2023 (4)
  • 8/25/2023China: The Latest Medtech Access Policies and Implications
  • 8/25/2023Patent Linkage in China: What the First Decisions Reveal About the Dir...
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/24/2023Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/23/2023NMPA Appoints New Director General of the CDE
  • 8/23/2023NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
  • 8/23/2023Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
  • 8/23/2023What China's New Patent Linkage and Patent Term Extension Systems Mean...
  • 8/23/2023Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
  • 8/22/2023Patent Linkage Litigation in China: A Two-Year Review (The NLR)
  • 8/22/2023Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
  • 8/22/2023CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
  • 8/22/2023Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
  • 8/22/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
  • 8/22/2023China Expands Reimbursement of Rare Disease Drugs to Improve Access: N...
  • 8/21/2023Moderna and CARsgen Join Forces to Combine mRNA Cancer Vaccine with CA...
  • 8/21/2023NHC: China's Health Literacy Improved in 2022
  • 8/18/2023NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
  • 8/18/2023Drug R&D and Product Registration News Digest August 2023 (3)
  • 8/18/2023Recent Executive Moves
  • 8/17/2023NMPA Announces Package Insert Revision of Three Drug Products
  • 8/17/2023NMPA Issues the List of Reference Formulations for GQCE Studies (71st ...
  • 8/17/2023NMPA Revises the Information Standard System for Drug Regulatory Digit...
  • Page:123/806 Total number of articles:24168: [First][<<] [121] [122] [123] [124] [125] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group